Suppr超能文献

中国海南自由贸易港:医疗法律与政策改革。

China's Hainan Free Trade Port: Medical Laws and Policy Reform.

机构信息

Law School, Hainan University, Haikou, China.

Danzhou City Construction Investment Co., Ltd., Danzhou, China.

出版信息

Front Public Health. 2021 Nov 15;9:764977. doi: 10.3389/fpubh.2021.764977. eCollection 2021.

Abstract

In 2018, the government of China decided to develop Hainan Province as the country's first free trade port operating within the country's socialist system. Based on this strategy, Hainan reformed its medical laws and policies to make it freer and more open. For example, Hainan formulated policies for more rapid and convenient access of foreign medicine and sanitary equipment (MSE), allowed manufacturers to register MSE in China with real-world data (RWD), and provided legal and visa conveniences for international medical teams to carry out various activities, including: diagnosis, treatment and scientific research. Hainan's reforms are not only conducive to the improvement of local medical and public health levels, but also provide opportunities for international MSE manufacturers and medical research institutions swiftly to enter China's huge medical market. However, with opportunity comes risk: Hainan should be on guard against public health risks associated with medical tourism, and decide how to strike a reasonable balance between protecting local MSE enterprises and improving the accessibility of imported MSE through policies and legislation. Finally, the paper recommends that Hainan should improve the regulatory system as soon as possible to ensure the quality of diagnosis and treatment in its new hospitals, and deal with data and information security risks in the RWD research.

摘要

2018 年,中国政府决定将海南省建设成为中国首个在社会主义制度下运行的自由贸易港。基于这一战略,海南对其医疗法律法规进行了改革,以实现更大程度的自由和开放。例如,海南制定了更快速、更便捷的政策,以促进外国药品和医疗器械(MSE)进入中国,允许制造商使用真实世界数据(RWD)在中国注册 MSE,并为国际医疗团队开展各种活动提供法律和签证便利,包括诊断、治疗和科研。海南的改革不仅有利于提高当地的医疗和公共卫生水平,也为国际 MSE 制造商和医疗机构迅速进入中国庞大的医疗市场提供了机会。然而,机遇伴随着风险:海南应该警惕与医疗旅游相关的公共卫生风险,并通过政策和立法,在保护本地 MSE 企业和提高进口 MSE 的可及性之间做出合理的权衡。最后,本文建议海南应尽快完善监管体系,确保新医院的诊断和治疗质量,并应对 RWD 研究中的数据和信息安全风险。

相似文献

1
China's Hainan Free Trade Port: Medical Laws and Policy Reform.
Front Public Health. 2021 Nov 15;9:764977. doi: 10.3389/fpubh.2021.764977. eCollection 2021.
2
Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
Public Health. 2017 Jan;142:73-84. doi: 10.1016/j.puhe.2016.10.007. Epub 2016 Nov 22.
3
Medical Insurance Information Systems in China: Mixed Methods Study.
JMIR Med Inform. 2020 Sep 1;8(9):e18780. doi: 10.2196/18780.
5
The development of local ambient air quality standards: A case study of Hainan Province, China.
Eco Environ Health. 2023 Oct 28;3(1):11-20. doi: 10.1016/j.eehl.2023.10.002. eCollection 2024 Mar.
7
Privatization of the medical market in socialist China: a historical approach.
Health Policy. 1994 Feb;27(2):157-74. doi: 10.1016/0168-8510(94)90078-7.
8
Engaging sub-national governments in addressing health equities: challenges and opportunities in China's health system reform.
Health Policy Plan. 2013 Dec;28(8):809-24. doi: 10.1093/heapol/czs120. Epub 2012 Dec 4.
9
Assessing the Risks of China's Medical Tourism from the Legal Perspective.
Risk Manag Healthc Policy. 2020 Oct 28;13:2291-2299. doi: 10.2147/RMHP.S271224. eCollection 2020.

引用本文的文献

1
The impact of free trade port construction on regional import and export: Evidence from Hainan.
PLoS One. 2025 Aug 13;20(8):e0328875. doi: 10.1371/journal.pone.0328875. eCollection 2025.
2
Governing cross-border healthcare in mainland China: a scoping review of national policies from 2002 to 2022.
Lancet Reg Health West Pac. 2024 Mar 14;45:101046. doi: 10.1016/j.lanwpc.2024.101046. eCollection 2024 Apr.
4
Prevalence and factors associated with pentavalent vaccination: a cross-sectional study in Southern China.
Infect Dis Poverty. 2023 Sep 15;12(1):84. doi: 10.1186/s40249-023-01134-8.
5
Long way to go: Progress of orphan drug accessibility in China from 2017 to 2022.
Front Pharmacol. 2023 Mar 8;14:1138996. doi: 10.3389/fphar.2023.1138996. eCollection 2023.

本文引用的文献

2
Guaranteeing the Health Rights of People with Disabilities in the COVID-19 Pandemic: Perspectives from China.
Risk Manag Healthc Policy. 2020 Oct 30;13:2357-2363. doi: 10.2147/RMHP.S273685. eCollection 2020.
3
Assessing the Risks of China's Medical Tourism from the Legal Perspective.
Risk Manag Healthc Policy. 2020 Oct 28;13:2291-2299. doi: 10.2147/RMHP.S271224. eCollection 2020.
4
Ripretinib: First Approval.
Drugs. 2020 Jul;80(11):1133-1138. doi: 10.1007/s40265-020-01348-2.
5
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
N Engl J Med. 2020 Feb 13;382(7):610-621. doi: 10.1056/NEJMoa1914510. Epub 2019 Dec 11.
6
Nontuberculous mycobacteria infection risk in medical tourism.
JAAPA. 2018 Aug;31(8):45-47. doi: 10.1097/01.JAA.0000541484.62234.7f.
7
When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?
Clin Pharmacol Ther. 2017 Dec;102(6):924-933. doi: 10.1002/cpt.857. Epub 2017 Sep 25.
8
From Evidence Based Medicine to Medicine Based Evidence.
Am J Med. 2017 Nov;130(11):1246-1250. doi: 10.1016/j.amjmed.2017.06.012. Epub 2017 Jul 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验